Developing an analytical workflow for nanomedicine and 3rd generation vaccine production at scale

Nanomedicines have the potential to revolutionize healthcare by prolonging the biological half-life of active ingredients, improving targeting, reducing toxicity and increasing bioavailability. In order to realize this promise, the pharmaceutical industry needs fit-for-purpose analytical methods that support cost-effective, large-scale production techniques for liposomal and lipid nanoparticle (LNP) delivery vectors.

With years of experience in the development and manufacturing of liposomal and LNP formulations, Polymun Scientific is leading the way in transforming this promising technology into production reality.


Not registered yet? Create an account